Vaxxas CEO David Hoey said, “We're honoured to have our world-leading microarray patch technology chosen to be part of this important BARDA-led public health initiative to accelerate new vaccine technologies."
Australian company Vaxxas named stage winner of US prize to advance vaccine patches
January 20, 2025 Australian BiotechLatest NewsLatest Video
New Stories
-
BioCina and NovaCina merger aims to bolster the global CDMO industry
January 21, 2025 - - Australian Biotech -
Australian company Vaxxas named stage winner of US prize to advance vaccine patches
January 20, 2025 - - Australian Biotech -
US issues list of next 15 medicines to face price negotiation power
January 20, 2025 - - Latest News -
Takeda named global top employer for eighth consecutive year
January 20, 2025 - - Latest News -
Stoking 'good' antibodies key to reducing serious bee venom allergic reactions
January 20, 2025 - - Australian Biotech -
'This is a world-leading approach to reduce the impact of RSV on babies'
January 20, 2025 - - Latest News -
New leadership for Boehringer Ingelheim as the company recognised as top employer
January 20, 2025 - - Latest News